Filter
2647
Filtered Results: 2647
Text search:
TB
drugs
Featured
Recommendations
244
New Publications
826
Language
Document type
No document type
1876
Guidelines
274
Studies & Reports
264
Manuals
76
Strategic & Response Plan
65
Fact sheets
30
Training Material
28
Situation Updates
17
Infographics
12
Resource Platforms
4
Online Courses
1
Countries / Regions
India
184
Kenya
105
South Africa
92
Ethiopia
69
Western and Central Europe
66
Uganda
65
Zambia
63
Nepal
60
Tanzania
59
Nigeria
57
Malawi
53
Sierra Leone
48
Global
46
Liberia
44
Rwanda
44
Eastern Europe
43
Africa
42
Bangladesh
37
Ghana
35
Myanmar / Burma
35
Ukraine
34
Namibia
33
Lesotho
33
Philippines
30
Asia
29
Cambodia
28
Zimbabwe
24
Indonesia
24
Latin America and the Carribbean
24
Botswana
20
South–East Asia Region
20
Senegal
14
Russia
14
Mozambique
13
Eswatini/ Swaziland
12
Colombia
12
Burkina Faso
11
East and Southern Africa
11
Congo, Democratic Republic of
10
Pakistan
10
Benin
9
Argentina
8
Peru
8
Germany
7
West and Central Africa
7
Albania
7
Haiti
6
South Sudan
6
Syria
6
Brazil
6
Tajikistan
6
Georgia
6
Cameroon
5
Thailand
5
Middle East and North Africa
5
Southern Africa
5
Afghanistan
4
Bolivia
4
Eastern Europe and Central Asia
4
Venezuela
4
Armenia
4
Laos
4
Vietnam
4
Guinea
3
Somalia
3
Jordan
3
Lebanon
3
Sudan
3
Sri Lanka
3
Western Pacific Region
3
Paraguay
3
Bhutan
3
Estonia
3
Moldova
3
Iran
3
USA
2
Saudi Arabia
2
Iraq
2
Papua New Guinea
2
North Macedonia
2
Burundi
2
Ecuador
2
El Salvador
2
Madagascar
2
Yemen
2
Poland
2
Timor Leste/ East Timor
2
Romania
2
North America
2
Uruguay
2
Mali
1
Morocco
1
Niger
1
Egypt
1
Gambia
1
Ireland
1
Singapore
1
Central African Republic
1
Hungary
1
Honduras
1
Greece
1
Libya
1
Angola
1
Guatemala
1
Mexico
1
Nicaragua
1
Chile
1
Solomon Islands
1
Palestine
1
North Korea
1
Djibouti
1
Mongolia
1
Qatar
1
Bulgaria
1
Gabon
1
Turkmenistan
1
Maldives
1
Tunisia
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
1252
Clinical Guidelines
216
Public Health
78
Women & Child Health
70
Key Resources
38
Capacity Building
34
Pharmacy & Technologies
24
Annual Report MEDBOX
1
Toolboxes
TB
516
HIV
440
AMR
101
Pharmacy
63
COVID-19
50
Mental Health
49
NTDs
49
Caregiver
42
Refugee
30
NCDs
25
Ebola
21
Conflict
20
Global Health Education
19
Polio
18
Health Financing Toolbox
18
Disability
15
Natural Hazards
11
Rapid Response
11
Planetary Health
9
Social Ethics
4
Specific Hazards
3
South Sudan
1
Zika
1
Health Financing
1
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed dr.... We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to standardised questionnaires and the Global TB Drug Facility website.
TB treatment for children is fundamentally the same as for adults, with a combination of TB drugs needing to be taken for a number of months. ... treatment for children consists of an intensive phase followed by a continuation phase. The purpose of the intensive phase is to rapidly eliminate the majority of the TB bacteria, and this phase uses a greater number of TB drugs than the continuation phase whose aim is to eradicate any remaining dormant bacteria.
Accessed Nov. 07. 2017
Accessed: 19.10.2019
Consolidated Guidelines
Geneva, 2016
The End TB Strategy
The END TB Strategy
Интеграция совместного оказания услуг в связи с ТБ и ВИЧ во всеобъемлющий пакет помощи для потребителей инъекционных нарко...
Key populations brief.
Key populations brief.
Краткое руководство
DNDi’s long-term goal for sleeping sickness, also known as human African trypanosomiasis (HAT), is to develop and register two new drugs that are effective against both Stage 1 and Stage 2 of the disease and both subspecies of the parasite, ....b. gambiense and T.b. rhodesiense. T.b. rhodesiense is an acute form of the disease, occurring primarily in Eastern and Southern Africa. Better treatments for T.b. rhodesiense sleeping sickness are urgently needed.
DNDi is now striving to make fexinidazole available to the majority of people who have T.b. gambiense sleeping sickness. We are supporting a three-year access and pharmacovigilance study that began in 2020 and have so far carried out in-country training of relevant staff in 250 hospitals and...
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key inte...
For the first time in almost 50 years there are two new drugs for the treatment of drug-resistant TB (DR-TB): bedaquiline and delamanid. There has ...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
Therapy for MDR-TB is extremely long, complex and burdensome to both patients and health care systems. A single diagnosis can require two years of treatment, or longer. When treating children, there are significant additional barriers treating child...
Accessed 2017
Please Download all Documents directly from the website: https://www.finddx.org/tb-laboratory-standard-operating-procedures-sops/
Laboratory Quality (TB01), General Procedures (TB02), Specimen Handling (TB03), Microscopy Procedures ...
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- an...
The third edition, released in 2018, has grown to include a total of 18 chapters, contributed by 20 experts and authors from many countries. The goal remains the same: to educate primary care providers on the best practices in TB diagnosis, treatmen...
A large meta-analysis of observational studies that provided the basis for the recent makeover of global recommendations for multidrug-resistant tuberculosis (MDR-TB) treatment shows that newer and repurposed ... produced better outcomes and fewer deaths than older treatments.
The meta-analysis of 50 studies involving 12,000 patients from 25 countries, published yesterday in The Lancet, found that bedaquiline, linezolid, levofloxacin, and moxifloxacin were associated with greater treatment success and reduced mortality compared with the previously recommended first-line treatments, while clofazimine and carbapenem antibiotics were associated with significantly improved treatment outcomes (but not reduced mortality)
Technical information note. Ensuring an uninterrupted supply of quality-assured, affordable anti-TB
drugs and diagnostics to the world
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have b...
